Clinicians Live: New Opportunities to Reduce Residual Risk Beyond Statin Therapy

This innovative symposium will provide in-depth coverage of key issues & guidelines surrounding the management of CV risk beyond statin therapy.
1.50 available credits
This innovative symposium will provide in-depth coverage of key issues & guidelines surrounding the management of CV risk beyond statin therapy.
1.50 available credits
Enroll in this meeting
May 16, 2019
06:45 PM - 08:15 PM EDT
Turnberry Isle Miami
Royal Ballroom 2, 19999 W Country Club Dr, Aventura, Florida, United States
Enrollment Fee: Free
Free
  • Overview

    This innovative and engaging symposium will provide in-depth coverage of key issues and guidelines surrounding the management of CV risk beyond statin therapy. Prominent, internationally known faculty will highlight relevant clinical pearls to improve patient management and clinical outcomes.

  • Program Schedule*

    6:45 pm–7:00 pm             

    Registration & Buffet Dinner

     

     

     

     

    7:00 pm–7:10 pm

    Program Overview

     

     

     

     

    7:10 pm–7:25 pm

    REDUCE-IT and Other Omega-3 Trials

     

     

     

     

    7:25 pm–7:40 pm

    Biologic Basis for EPA Modulation in Reducing ASCVD Events Seen in REDUCE-IT

     

     

     

     

    7:40 pm–7:55 pm

    Clinician Live Discussion

     

     

     

     

    7:55 pm–8:10 pm

    Q& A with the Audience

     

     

     

     

    8:10 pm–8:25 pm

    Challenging Cases for Discussion

     

     

     

     

    8:25 pm–8:30 pm

    Closing Comments

     

     
    8:30 pm

     
    Adjourn

     

    *Topics subject to change

  • Faculty

    Sergio Fazio, MD, PhD, Chair
    R. Preston Mason, PhD
    Michael Miller, MD
    Margo B. Minissian, PhD
    James A. Underberg, MD 

  • Learning Objectives

    At the conclusion of this activity, participants should be able to:

    • Discuss the results and importance of REDUCE-IT and other recent cardiovascular outcomes trials that reduce ASCVD events beyond statin therapy.
    • Describe the potential biologic basis for the reductions in ASCVD events observed in REDUCE-IT.
    • Apply evidence-based trial data and guidelines to lifestyle and therapeutic approaches for managing patients with or at high risk of ASCVD events.
    • Discuss strategies to improve the knowledge, skills or performance of the healthcare team.
  • Target Audience

    This activity is designed to meet the needs of lipidologists, internists, endocrinologists, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses and registered dietitians with an interest in lipid management.

  • Disclaimer

    This is an independent satellite CME/CE symposium held in conjunction with the NLA 2019 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.

  • Accreditation and Credit Designation

    CME Credit Provided by the National Lipid Association
    In support of improving patient care, this activity has been planned and implemented by The National Lipid Association and Medtelligence. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Physician Credit Designation Statement
    The National Lipid Association designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

    Physician Assistants
    NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

    Dietitians
    The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1.50 continuing professional education units (CPEUs) for completion of this program/materials. CDR Accredited Provider #NL002.

    Pharmacists
    Universal Activity Number – JA0007192-9999-19-011-L01-P (Application) 
    This Activity has been approved for 1.50 contact hour(s) (.150 CEUs) of the Accreditation Council for Pharmacy Education.

    Nursing
    The maximum number of hours awarded for this CE activity is 1.5 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

    Activity Type
    Live, Application

    Criteria for Success
    Statements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme
    For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

  • Commercial Support

    Supported by an independent educational grant from Amarin Pharma, Inc.

  • Americans with Disabilities Act

    Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc.). Please contact Milly Marte prior to the live event at mmarte@medtelligence.net.
    There is no fee for this educational activity.

  • Sponsorship

    This activity is jointly provided by the National Lipid Association in collaboration with Medtelligence.

Facebook Comments

Sign up for the Medtelligence newsletters.
Comprehensive Cardiology Education.

Better education for a better you.

* Required
Optional
Register

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free